ATRA- Atara Biotherapeutics, Inc.

Name: Atara Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Atara Biotherapeutics, Inc. (ATRA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Panacea Innovation Ltd	1.32M	$11.05M	-
10%	Adiumentum Capital Fund I LP	377.2K	$3.15M	-
CEO	Nguyen Anhco	143.1K	$1.19M	-
?	Touchon Pascal	78.0K	$650.1K	-
Other	Grant-Huerta Yanina	52.0K	$434.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 8, 2021	Koppikar Utpal76	Chief Financial Officer	Sell	1,759	$20.39	$35,866.01	-1.3%	-36.1%	-26.5%
Feb 8, 2021	Newell Joe85	Chief Operations Officer	Sell	3,886	$20.39	$79,235.54	-3.5%	-36.1%	-26.5%
Jan 15, 2021	Newell Joe85	Chief Operations Officer	Sale+OE	7,000	$18.84	$131,880.00	-6.0%	-	-
Dec 16, 2020	Newell Joe85	Chief Operations Officer	Sale+OE	7,000	$23.11	$161,735.00	-3.0%	-	-
Nov 17, 2020	Koppikar Utpal76	Chief Financial Officer	Sell	1,469	$19.77	$29,048.01	-1.1%	-	-
Nov 17, 2020	Newell Joe85	Chief Operations Officer	Sell	1,648	$19.77	$32,587.55	-1.4%	-	-
Nov 17, 2020	Touchon Pascal82	President And CEO	Sell	4,716	$19.77	$93,254.18	-1.8%	-	-
Nov 13, 2020	Newell Joe85	Chief Operations Officer	Sale+OE	7,500	$18.49	$138,688.00	-3.1%	-	-
Aug 18, 2020	Touchon Pascal82	President And CEO	Sell	4,807	$12.09	$58,116.63	-1.8%	-	-
Aug 18, 2020	Koppikar Utpal76	Chief Financial Officer	Sell	1,496	$12.09	$18,086.64	-1.1%	-	-

← PrevPage 12Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC